Citations for
1CLCN1, DM2
Novel mutations in the CLCN1 gene of myotonia congenita: 2 case reports.
Lakraj AA, Miller G, Vortmeyer AO, Khokhar B, Nowak RJ, DiCapua DB.
Yale J Biol Med 86(1):101-6. Epub 2013 Mar 12. 2013
2CELF1, DM1, DM2
Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2.
Cardani R, Bugiardini E, Renna LV, Rossi G, Colombo G, Valaperta R, Novelli G, Botta A, Meola G.
PLoS One 8(12):e83777. doi: 10.1371/journal.pone.0083777. 2013
3CNBP, DM1, DM2, DMPK
Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challenges.
Sicot G, Gourdon G, Gomes-Pereira M.
Hum Mol Genet 20(R2):R116-23. doi: 10.1093/hmg/ddr343. Epub 2011 Aug 5. Review. 2011
4DM2, MBNL1
Selective inhibition of MBNL1-CCUG interaction by small molecules toward potential therapeutic agents for myotonic dystrophy type 2 (DM2).
Wong CH, Fu Y, Ramisetty SR, Baranger AM, Zimmerman SC.
Nucleic Acids Res 39(20):8881-90. doi: 10.1093/nar/gkr415. Epub 2011 Jul 18. 2011
5CLCN1, CNBP, DM2, MCB, MCT
Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene.
Sun C, Van Ghelue M, Tranebjærg L, Thyssen F, Nilssen Ø, Torbergsen T.
Clin Genet 80(6):574-80. doi: 10.1111/j.1399-0004.2010.01616.x. Epub 2011 Jan 19. 2011
6DM1, DM2, LDB3
Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2.
Vihola A, Bachinski LL, Sirito M, Olufemi SE, Hajibashi S, Baggerly KA, Raheem O, Haapasalo H, Suominen T, Holmlund-Hampf J, Paetau A, Cardani R, Meola G, Kalimo H, Edström L, Krahe R, Udd B.
Acta Neuropathol 119(4):465-79. doi: 10.1007/s00401-010-0637-6. Epub 2010 Jan 12. 2010
7CNBP, DM1, DM2
Absence of a differentiation defect in muscle satellite cells from DM2 patients.
Pelletier R, Hamel F, Beaulieu D, Patry L, Haineault C, Tarnopolsky M, Schoser B, Puymirat J.
Neurobiol Dis 36(1):181-90. Epub 2009 Jul 24.PMID: 19632331 2009
8CNBP, DM2
Reduction of the rate of protein translation in patients with myotonic dystrophy 2.
Huichalaf C, Schoser B, Schneider-Gold C, Jin B, Sarkar P, Timchenko L.
J Neurosci 29(28):9042-9.PMID: 19605641 2009
9DM2
Myotonic dystrophy type 2 found in two of sixty-three persons diagnosed as having fibromyalgia.
Auvinen S, Suominen T, Hannonen P, Bachinski LL, Krahe R, Udd B.
Arthritis Rheum 58(11):3627-31.PMID: 18975316 2008
10CNBP, DM2
Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion.
Lucchiari S, Pagliarani S, Corti S, Mancinelli E, Servida M, Fruguglietti E, Sansone V, Moggio M, Bresolin N, Comi GP, Meola G.
J Neurol Sci 275(1-2):159-63. Epub 2008 Sep 18.PMID: 18804219 2008
11CNBP, DM2
Type 2 myotonic dystrophy can be predicted by the combination of type 2 muscle fiber central nucleation and scattered atrophy.
Bassez G, Chapoy E, Bastuji-Garin S, Radvanyi-Hoffman H, Authier FJ, Pellissier JF, Eymard B, Gherardi RK.
J Neuropathol Exp Neurol 67(4):319-25.PMID: 18379436 2008
12CNBP, DM1, DM2, DMPK
Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH, Tapscott SJ.
Biochim Biophys Acta 1772(2):195-204. Epub 2006 Jun 20. Review. 2007
13DM2, CNBP
DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression.
Margolis JM, Schoser BG, Moseley ML, Day JW, Ranum LP.
Hum Mol Genet 15(11):1808-15. Epub 2006 Apr 19. 2006
14CNBP, DM2
Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population.
Vallo L, Bonifazi E, Borgiani P, Novelli G, Botta A.
Mol Cell Probes 19(1):71-4. Epub 2004 Nov 12. 2005
15FXN, FRDA, FRAXA, FMR1, FRAXE, ATXN1, SCA1, ATXN2, SCA2, ATXN3, MJD, ATXN7, SCA7, SCA6, CACNA1A, SCA17, TBP, DRPLA, ATN1, AR, SBMA, DM1, DMPK, DM2, CNBP, SCA10, ATXN10, SCA12, PPP2R2B, SCA8, ATXN8OS
Diseases of unstable repeat expansion: mechanisms and common principles.
Gatchel JR, Zoghbi HY.
Nat Rev Genet 6(10):743-55. Review. 2005
16DM2, CNBP, DM1, DMPK
Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease.
Maurage CA, Udd B, Ruchoux MM, Vermersch P, Kalimo H, Krahe R, Delacourte A, Sergeant N.
Neurology 65(10):1636-8. 2005
17DM1, DM2, INSR
Insulin receptor splicing alteration in myotonic dystrophy type 2.
Savkur RS, Philips AV, Cooper TA, Dalton JC, Moseley ML, Ranum LP, Day JW.
Am J Hum Genet 74(6):1309-13. Epub 2004 Apr 26. 2004
18DM2, CNBP
Homozygosity for CCTG mutation in myotonic dystrophy type 2.
Schoser BG, Kress W, Walter MC, Halliger-Keller B, Lochmuller H, Ricker K.
Brain 127(Pt 8):1868-77. Epub 2004 Jul 1. 2004
19DM2
PROMM and deafness: exclusion of ZNF9 as the disease gene in DFNA18 suggests a polygenic origin of the PROMM/DM2 phenotype
Bonsch D, Neumann C, Lang-Roth R, Witte O, Lamprecht-Dinnesen A, Deufel T.
Clin Genet 63(1):73-5. No abstract available. 2003
20DM2, CNBP
Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.
Bachinski LL, Udd B, Meola G, Sansone V, Bassez G, Eymard B, Thornton CA, Moxley RT, Harper PS, Rogers MT, Jurkat-Rott K, Lehmann-Horn F, Wieser T, Gamez J, Navarro C, Bottani A, Kohler A, Shriver MD, Sallinen R, Wessman M, Zhang S, Wright FA, Krahe R.
Am J Hum Genet 73(4):835-48. Epub 2003 Sep 10. 2003
21DM2, CNBP
Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract.
Liquori CL, Ikeda Y, Weatherspoon M, Ricker K, Schoser BG, Dalton JC, Day JW, Ranum LP.
Am J Hum Genet 73(4):849-62. Epub 2003 Sep 22. 2003
22DM2, CNBP
Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum.
Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, Schneider C, Koch MC, Beilman GJ, Harrison AR, Dalton JC, Ranum LP.
Neurology 60(4):657-64. 2003
23DM1, DM2
Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2.
Vihola A, Bassez G, Meola G, Zhang S, Haapasalo H, Paetau A, Mancinelli E, Rouche A, Hogrel JY, Laforet P, Maisonobe T, Pellissier JF, Krahe R, Eymard B, Udd B.
Neurology 60(11):1854-7. 2003
24DM1, DM2
Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2.
Mankodi A, Teng-Umnuay P, Krym M, Henderson D, Swanson M, Thornton CA.
Ann Neurol 54(6):760-8. 2003
25DFNA8, DFNB15, DM2
A novel locus for autosomal dominant, non-syndromic hearing impairment (DFNA18) maps to chromosome 3q22 immediately adjacent to the DM2 locus.
Bonsch D, Scheer P, Neumann C, Lang-Roth R, Seifert E, Storch P, Weiller C, Lamprecht-Dinnesen A, Deufel T.
Eur J Hum Genet 9(3):165-70. 2001
26DM2,CNBP
Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.
Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP.
Science 293(5531):864-7. 2001
27DM2
Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2).
Day JW, et al.
Neuromuscul Disord 9(1):19-27 1999
28DM2
Linkage of proximal myotonic myopathy to chromosome 3q.
Ricker K, et al.
Neurology 52(1):170-1 1999
29DM2
Genetic mapping of a second myotonic dystrophy locus.
Ranum LPW, et al.
Nat Genet 19 : 196-198. 1998